Profound Medical Corp. earnings releases PROF

Profound Medical Corp. last reported quarterly results on Oct 7, 2026, for Q3 FY2026 (the quarter ended Sep 30, 2026): revenue of $9.8 million (+85.9% year over year) and diluted EPS of -$0.21. It usually reports 7–64 days after a quarter ends. Based on that pattern, the next release is estimated for around Mar 4, 2027.

Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 7–64 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.

Released Quarter Revenue Net income Diluted EPS
Oct 7, 2026
7 days after quarter end
Q3 FY2026
ended Sep 30, 2026
10
+85.9%
-8
+3.2%
-0.21
+19.2%
Aug 6, 2026
37 days after quarter end
Q2 FY2026
ended Jun 30, 2026
2
+12.3%
-10
+39.2%
-0.26
+50.0%
May 7, 2026
37 days after quarter end
Q1 FY2026
ended Mar 31, 2026
5
+103.6%
-7
+34.2%
0.19
-47.2%
Mar 5, 2026
64 days after quarter end
Q4 FY2025
ended Dec 31, 2025
6
-8
2.52
Oct 7, 2025
7 days after quarter end
Q3 FY2025
ended Sep 30, 2025
5
-8
-0.26
Aug 14, 2025
45 days after quarter end
Q2 FY2025
ended Jun 30, 2025
2
-16
-0.52
May 8, 2025
38 days after quarter end
Q1 FY2025
ended Mar 31, 2025
3
-11
0.36
Jan 8, 2025
8 days after quarter end
—
ended Dec 31, 2024
—
—
—

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
PROF (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Ontario, Canada
Headquarters
Mississauga, Ontario, Canada
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1628808

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.